Found: 11
Select item for more details and to access through your institution.
RECAM‐J 2023—Validation and development of the Japanese version of RECAM for the diagnosis of drug‐induced liver injury.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 503, doi. 10.1111/hepr.14046
- By:
- Publication type:
- Article
Concordance between metabolic dysfunction‐associated steatotic liver disease and nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 600, doi. 10.1111/hepr.14011
- By:
- Publication type:
- Article
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real‐world study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 575, doi. 10.1111/hepr.14007
- By:
- Publication type:
- Article
Impact of metabolic dysfunction‐associated fatty liver disease on the incidence of Helicobacter pylori‐negative gastric cancer.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 540, doi. 10.1111/hepr.14010
- By:
- Publication type:
- Article
Differential peripheral memory T cell subsets sensitively indicate the severity of nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 525, doi. 10.1111/hepr.14009
- By:
- Publication type:
- Article
Development and validation of a prognostic model for 90‐day survival in patients with alcohol‐associated cirrhosis and acute decompensation.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 588, doi. 10.1111/hepr.14006
- By:
- Publication type:
- Article
A case of A20 haploinsufficiency complicated by autoimmune hepatitis.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 606, doi. 10.1111/hepr.14003
- By:
- Publication type:
- Article
The change in Fibrosis‐4 index in Japanese patients with type 2 diabetes treated by a fixed‐ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 513, doi. 10.1111/hepr.14002
- By:
- Publication type:
- Article
Prognostic significance of C‐reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 562, doi. 10.1111/hepr.14001
- By:
- Publication type:
- Article
Potential role of Fibrosis‐4 score in hepatocellular carcinoma screening: The Kangbuk Samsung Health Study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 551, doi. 10.1111/hepr.13999
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 501, doi. 10.1111/hepr.13918
- Publication type:
- Article